Aglycon of rhizochalin from the Rhizochalina incrustata induces apoptosis via activation of AMP-activated protein kinase in HT-29 colon cancer cells

Biological and Pharmaceutical Bulletin

Volumn 34, Issue 10, 2011, Pages 1553-1558

  Khanal, Prem ^a   Kang, Bong Seok ^b   Yun, Hyo Jeong ^a   Cho, Hae Guk ^a   Makarieva, Tatyana Nikolaevna ^c   Choi, Hong Seok ^a  

^a Chosun University   (South Korea)

^b Kyungpook National University Hospital   (South Korea)

^c PACIFIC INSTITUTE OF BIOORGANIC CHEMISTRY   (Russian Federation)

Author keywords

AMP activated protein kinase; c Fos; c Jun; Cell transformation; Rhizochalin

Indexed keywords

AGLYCONE; ANTINEOPLASTIC AGENT; CASPASE 3; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; MAMMALIAN TARGET OF RAPAMYCIN; MITOGEN ACTIVATED PROTEIN KINASE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN C FOS; RHIZOCHALIN; SOMATOMEDIN C; TRANSCRIPTION FACTOR AP 1; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CARCINOGENICITY; CELL TRANSFORMATION; COLON CANCER; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA FRAGMENTATION; DOWN REGULATION; DRUG EFFECT; DRUG POTENCY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; MOLECULAR DYNAMICS; RHIZOCHALINA INCRUSTATA; SIGNAL TRANSDUCTION; SPONGE (PORIFERA);

AMP-ACTIVATED PROTEIN KINASES; ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CASPASE 3; CELL TRANSFORMATION, NEOPLASTIC; CHEMOPREVENTION; COLONIC NEOPLASMS; DNA FRAGMENTATION; DRUG EVALUATION, PRECLINICAL; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FATTY ALCOHOLS; GLYCOSPHINGOLIPIDS; HT29 CELLS; HUMANS; MICE; MITOGEN-ACTIVATED PROTEIN KINASES; MOLECULAR TARGETED THERAPY; OCEANS AND SEAS; PHOSPHORYLATION; PHYTOTHERAPY; PLANT PREPARATIONS; POLY(ADP-RIBOSE) POLYMERASES; PORIFERA; PROTEIN-SERINE-THREONINE KINASES; TETRAZOLIUM SALTS; THIAZOLES; TOR SERINE-THREONINE KINASES; TUMOR CELLS, CULTURED;

EID: 80053522700     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.34.1553     Document Type: Article

References (39)

1. Makarieva T. N., Guzii A. G., Denisenko V. A., Dmitrenok P. S., Santalova E. A., Pokanevich E. V., Molinski T. F., Stonik V. A., J. Nat. Prod., 68, 255-257 (2005).
2. Fedorov S. N., Makarieva T. N., Guzii A. G., Shubina L. K., Kwak J. Y., Stonik V. A., Lipids, 44, 777-785 (2009).
3. Jin J. O., Shastina V., Park J. I., Han J. Y., Makarieva T., Fedorov S., Rasskazov V., Stonik V., Kwak J. Y., Biol. Pharm. Bull., 32, 955-962 (2009).
4. Fay J. R., Steele V., Crowell J. A., Cancer Prev. Res. (Philadelphia), 2, 301-309 (2009).
5. Shaw R. J., Kosmatka M., Bardeesy N., Hurley R. L., Witters L. A., DePinho R. A., Cantley L. C., Proc. Natl. Acad. Sci. U.S.A., 101, 3329-3335 (2004).
6. Ben Sahra I., Laurent K., Loubat A., Giorgetti-Peraldi S., Colosetti P., Auberger P., Tanti J. F., Le Marchand-Brustel Y., Bost F., Oncogene, 27, 3576-3586 (2008).
7. Zakikhani M., Dowling R., Fantus I. G., Sonenberg N., Pollak M., Cancer Res., 66, 10269-10273 (2006).
8. Buzzai M., Jones R. G., Amaravadi R. K., Lum J. J., DeBerardinis R. J., Zhao F., Viollet B., Thompson C. B., Cancer Res., 67, 6745-6752 (2007).
9. Garcia-Gil M., Bertini F., Pesi R., Voccoli V., Tozzi M. G., Camici M., Nucleosides Nucleotides Nucleic Acids, 25, 1265-1270 (2006).
10. Kefas B. A., Cai Y., Kerckhofs K., Ling Z., Martens G., Heimberg H., Pipeleers D., van de Casteele M., Biochem. Pharmacol., 68, 409-416 (2004).
11. Isakovic A., Harhaji L., Stevanovic D., Markovic Z., Sumarac-Dumanovic M., Starcevic V., Micic D., Trajkovic V., Cell. Mol. Life Sci., 64, 1290-1302 (2007).
12. Cantrell L. A., Zhou C., Mendivil A., Malloy K. M., Gehrig P. A., Bae-Jump V. L., Gynecol. Oncol., 116, 92-98 (2010).
13. Khanal P., Oh W. K., Thuong P. T., Cho S. D., Choi H. S., Planta Med., 76, 689-693 (2010).
14. Kim H. J., Kim S. K., Kim B. S., Lee S. H., Park Y. S., Park B. K., Kim S. J., Kim J., Choi C., Kim J. S., Cho S. D., Jung J. W., Roh K. H., Kang K. S., Jung J. Y., J. Agric. Food Chem., 58, 8643-8650 (2010).
15. Fogarty S., Hardie D. G., Biochim. Biophys. Acta, 1804, 581-591 (2010).
16. Shaw R. J., Acta Physiol. (Oxford), 196, 65-80 (2009).
17. Pullen N., Thomas G., FEBS Lett., 410, 78-82 (1997).
18. Dufner A., Thomas G., Exp. Cell Res., 253, 100-109 (1999).
19. Lee N. Y., Choi H. K., Shim J. H., Kang K. W., Dong Z., Choi H. S., Carcinogenesis, 30, 671-681 (2009).
20. Karin M., J. Biol. Chem., 270, 16483-16486 (1995).
21. Eferl R., Wagner E. F., Nat. Rev. Cancer, 3, 859-868 (2003).
22. Dong Z., Cmarik J. L., Sci. STKE, 2002, p17 (2002).
23. Simmons T. L., Andrianasolo E., McPhail K., Flatt P., Gerwick W. H., Mol. Cancer Ther., 4, 333-342 (2005).
24. Sipkema D., Franssen M. C., Osinga R., Tramper J., Wijffels R. H., Mar. Biotechnol., 7, 142-162 (2005).
25. Gusman J., Malonne H., Atassi G., Carcinogenesis, 22, 1111-1117 (2001).
26. Hwang J.-T., Kwak D. W., Lin S. K., Kim H. M., Kim Y. M., Park O. J., Ann. N. Y. Acad. Sci., 1095, 441-448 (2007).
27. Zhou G., Myers R., Li Y., Chen Y., Shen X., Fenyk-Melody J., Wu M., Ventre J., Doebber T., Fujii N., Musi N., Hirshman M. F., Goodyear L. J., Moller D. E., J. Clin. Invest., 108, 1167-1174 (2001).
28. Rodgers-Garlick C. I., Armstrong G. A., Robertson R. M., J. Neurosci., 31, 3207-3216 (2011).
29. Inoki K., Zhu T., Guan K. L., Cell, 115, 577-590 (2003).
30. Gwinn D. M., Shackelford D. B., Egan D. F., Mihaylova M. M., Mery A., Vasquez D. S., Turk B. E., Shaw R. J., Mol. Cell, 30, 214-226 (2008).
31. Shaw R. J., Curr. Opin. Cell Biol., 18, 598-608 (2006).
32. Hay N., Sonenberg N., Genes Dev., 18, 1926-1945 (2004).
33. Dann S. G., Selvaraj A., Thomas G., Trends Mol. Med., 13, 252-259 (2007).
34. Pollak M. N., Schernhammer E. S., Hankinson S. E., Nat. Rev. Cancer, 4, 505-518 (2004).
35. Grimberg A., Cancer Biol. Ther., 2, 630-635 (2003).
36. Shaul Y. D., Seger R., Biochim. Biophys. Acta, 1773, 1213-1226 (2007).
37. Matthews C. P., Colburn N. H., Young M. R., Curr. Cancer Drug Targets, 7, 317-324 (2007).
38. Shaulian E., Karin M., Nat. Cell Biol., 4, E131-E136 (2002).
39. Chitnis M. M., Yuen J. S., Protheroe A. S., Pollak M., Macaulay V. M., Clin. Cancer Res., 14, 6364-6370 (2008).